NCT06616636
A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
Phase: Phase 1
Role: Collaborator
Start: Jan 30, 2025
Completion: Aug 27, 2029